BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 32643536)

  • 1. Exploration and evaluation of bioactive phytocompounds against BRCA proteins by
    Prabhavathi H; Dasegowda KR; Renukananda KH; Lingaraju K; Naika HR
    J Biomol Struct Dyn; 2021 Sep; 39(15):5471-5485. PubMed ID: 32643536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of Potential Phytochemicals from Carica papaya Targeting BRCA-1 in Breast Cancer Treatment.
    Ibrahim A; Ipinloju N; Aiyelabegan AO; Alfa-Ibrahim AA; Muhammad SA; Oyeneyin OE
    Appl Biochem Biotechnol; 2023 Dec; 195(12):7159-7175. PubMed ID: 36988843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Characterization,
    Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
    Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Hammoudi NE; Benguerba Y; Attoui A; Hognon C; Lemaoui T; Sobhi W; Benaicha M; Badawi M; Monari A
    J Biomol Struct Dyn; 2022 Feb; 40(2):886-902. PubMed ID: 32948119
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Rolta R; Yadav R; Salaria D; Trivedi S; Imran M; Sourirajan A; Baumler DJ; Dev K
    J Biomol Struct Dyn; 2021 Nov; 39(18):7017-7034. PubMed ID: 32851912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophore modeling, molecular docking and molecular dynamics simulation for screening and identifying anti-dengue phytocompounds.
    Vora J; Patel S; Athar M; Sinha S; Chhabria MT; Jha PC; Shrivastava N
    J Biomol Struct Dyn; 2020 Apr; 38(6):1726-1740. PubMed ID: 31057055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of HER2 inhibitors from curcumin derivatives using combination of
    Saibu OA; Singh G; Olugbodi SA; Oluwafemi AT; Ajayi TM; Hammed SO; Oladipo OO; Odunitan TT; Omoboyowa DA
    J Biomol Struct Dyn; 2023; 41(21):12328-12337. PubMed ID: 36752338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural compounds as potential Hsp90 inhibitors for breast cancer-Pharmacophore guided molecular modelling studies.
    Rampogu S; Parate S; Parameswaran S; Park C; Baek A; Son M; Park Y; Park SJ; Lee KW
    Comput Biol Chem; 2019 Dec; 83():107113. PubMed ID: 31493740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Maruthanila VL; Elancheran R; Mirunalini S
    Curr Comput Aided Drug Des; 2022; 18(3):196-212. PubMed ID: 35598239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
    Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
    J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor potentially stable conformations from molecular dynamics as a structure-based pharmacophore model for mapping, screening, and identifying ligands-a new paradigm shift in pharmacophore screening.
    Shanmugarajan D; David C
    J Biomol Struct Dyn; 2023 Jul; 41(11):4939-4948. PubMed ID: 35543232
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Samreen ; Qais FA; Ahmad I
    J Biomol Struct Dyn; 2023 Apr; 41(6):2189-2201. PubMed ID: 35067192
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Parvizpour S; Elengoe A; Alizadeh E; Razmara J; Shamsir MS
    J Biomol Struct Dyn; 2023 Nov; 41(19):10037-10050. PubMed ID: 36451602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of phyto-compounds as novel inhibitors against
    Kar B; Kundu CN; Pati S; Bhattacharya D
    J Biomol Struct Dyn; 2023 Mar; 41(4):1267-1280. PubMed ID: 34961397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of phytochemicals as potential anti-breast cancer agents targeting HER2: an in-silico approach.
    Lamichhane S; Rai RP; Khatri A; Adhikari R; Shrestha BG; Shrestha SK
    J Biomol Struct Dyn; 2023 Feb; 41(3):897-911. PubMed ID: 34957911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular docking and dynamic simulation to identify potential phytocompound inhibitors for EGFR and HER2 as anti-breast cancer agents.
    Prabhavathi H; Dasegowda KR; Renukananda KH; Karunakar P; Lingaraju K; Raja Naika H
    J Biomol Struct Dyn; 2022 Jul; 40(10):4713-4724. PubMed ID: 33345701
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Alamri A; Rauf A; Khalil AA; Alghamdi A; Alafnan A; Alshammari A; Alshammari F; Malik JA; Anwar S
    Biomed Res Int; 2021; 2021():9734279. PubMed ID: 34957309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of potential mTOR inhibitors from Cichorium intybus to find new candidate drugs targeting the pathological protein related to the breast cancer: an integrated computational approach.
    Rasul HO; Aziz BK; Ghafour DD; Kivrak A
    Mol Divers; 2023 Jun; 27(3):1141-1162. PubMed ID: 35737256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based pharmacophore modeling, virtual screening and simulation studies for the identification of potent anticancerous phytochemical lead targeting cyclin-dependent kinase 2.
    Sharma M; Sharma N; Muddassir M; Rahman QI; Dwivedi UN; Akhtar S
    J Biomol Struct Dyn; 2022; 40(20):9815-9832. PubMed ID: 34151738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.